Aleva Neurotherapeutics
PrivateLast Round
Series E
Dec 16, 2019
Total Funding Raised
$56.97M
Company Overview
Aleva Neurotherapeutics is a medical device company that develops, manufactures, and commercializes implantable deep brain stimulation (DBS) systems for the treatment of neurological diseases such as Parkinson's and essential tremor.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aleva Neurotherapeutics Comparables
Compare Aleva Neurotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Newronika | 87% | |
| Beijing PINS Medical Co., Ltd. | 85% | |
| 景昱医疗科技（苏州）股份有限公司 | 83% | |
Aleva Neurotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Dec 16, 2019 | ||||
| Series D | Oct 3, 2017 | ||||
| Series C | May 27, 2016 | ||||
| Series B | Apr 10, 2012 | ||||
| Series A | Aug 26, 2011 |
Aleva Neurotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioMedPartners | Series B, Series C, Series E, Series D |
| Kreaxi | Series C, Series E, Series D, Series B |
| BB Biotech Ventures | Series C, Series E, Series D |
| Kinled Holding | Series C, Series E, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2016
$18M round led by Integer Holdings Corporation.
- Apr 10, 2012
$4.38M round led by Kreaxi
Aleva Neurotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aleva Neurotherapeutics's valuation, stock price, and market status.